@DrPujaMehta1 @ElenaNikiUK@lancet@dfmcauley@R_tattersall @JessicaJManson @ucl https://t.co/3OjZsxX6da. Due to the complexity of cytokine interactions modifying their activities is unlikely to benefit patients with sepsis - ie cytokine storm
EULAR Guidance for patients with rheumatic musculoskeletal diseases (RMDs) about COVID-19 outbreak. Protect yourself & others.
Read the full guidance:
https://t.co/nFp9Brmv3T
#EULAR#FightingRMDsTogether#eularPARE
Many drugs are being carefully tested against COVID19. 4 standouts optimism high: 2 that kill the virus- Remdesivir (anti-Ebola)and combo Ritonavir/Lopinavir (anti-HIV), and 2 anti-inflammatories to protect lungs (hydroxychloroquine (anti-malaria) and tocilizumab (anti-IL6).
3rd THREAD:
Summarising unfolding research picture on #COVID19 as the outbreak enters its 3rd month with more data being reported out of China.
This thread compiles scientific data (with direct links to papers) on what we know so far on #COVID19#SARSCoV2#IDTwitter
📢 CORONAVIRUS ADVICE 📢
We have had a few calls from people with axial spondyloarthritis (axial SpA) including ankylosing spondylitis (AS) who are taking biologic therapy and are concerned about #coronavirus, and we have published this advice today. https://t.co/mOhAJ5Bx7I
Delivering a talk to junior doctors and would like some more ideas:
What do you wish you knew about Parkinson’s disease as a junior doctor?
Thanks in advance! @BGSMDS@GeriSoc